Calcipotriene And Betamethasone Dipropionate Suspension
Product Images NDC 0713-0848

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Calcipotriene And Betamethasone Dipropionate (NDC 0713-0848). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cosette Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Calcipotriene Chemical Structure (Calcipotriene And Betamethasone Dipropionate Topic 1)

Calcipotriene Chemical Structure (Calcipotriene And Betamethasone Dipropionate Topic 1)
FDA Label Image

Betamethasone Chemical Structure (Calcipotriene And Betamethasone Dipropionate Topic 2)

Betamethasone Chemical Structure (Calcipotriene And Betamethasone Dipropionate Topic 2)
FDA Label Image

Diagram Of Instructions For Use (Calcipotriene And Betamethasone Dipropionate Topic 3)

Diagram Of Instructions For Use (Calcipotriene And Betamethasone Dipropionate Topic 3)
This text provides a step-by-step guide on how to use calcipotriene and betamethasone dipropionate topical suspension for treating scalp affected by plaque psoriasis. It includes instructions on shaking the bottle, applying the medication to the affected area, and important tips such as washing hands after application and not washing the hair immediately afterward.*
FDA Label Image

120 Carton (Calcipotriene And Betamethasone Dipropionate Topic 4)

120 Carton (Calcipotriene And Betamethasone Dipropionate Topic 4)
FDA Label Image

60 Carton (Calcipotriene And Betamethasone Dipropionate Topic 5)

60 Carton (Calcipotriene And Betamethasone Dipropionate Topic 5)
This text describes a prescription medication in the form of a topical suspension containing Calcipotriene and Betamethasone Dipropionate. It provides instructions on shaking before use, storage conditions, dosage, and safety precautions. The medication should be kept out of reach of children and unused product should be discarded six months after opening. It also includes details about the manufacturer and distribution information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.